Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Mergers And Acquisition

Kiadis calls up Cytosen
University of Central Florida's Cytosen has been acquired in an all-stock deal by Kiadis Pharma, in a transaction potentially worth up to $70m.
Merck tackles $773m Tilos acquisition
Merck & Co will pay up to $773m to acquire biopharmaceutical developer Tilos Therapeutics, based on research at Harvard Medical School and Brigham & Women’s Hospital.
Salesforce processes $15.7bn Tableau acquisition
Stanford spinout Tableau Software has agreed to a $15.7bn all-stock acquisition by Salesforce, six years after completing a $254m initial public offering on the New York Stock Exchange.
Eriez activates majority role in FaultCurrent
Eriez is now the largest shareholder in Cardiff University-founded power fault protection technology spinout FaultCurrent, having previously invested a seven-figure sum.
Bio-Techne sweeps up B-Mogen
Bio-Techne has bought University of Minnesota-founded genome editing platform operator B-Mogen Biotechnologies to solidify a business relationship that dates to 2016.
Twitter absorbs Fabula AI
USI-founded fake news detection technology developer Fabula AI has been scooped up by Twitter, which will employ the spinout's talent to remove spam and abuse from its platform.
Ultrahaptics and Leap Motion to fuse operations for $30m
Bristol-founded haptics platform developer Ultrahaptics is set to absorb Leap Motion's patents and employees, succeeding in a transaction that Apple failed to complete twice.
Mindbody fastens onto
A member of NYU's Future Labs incubator network, virtual receptionist developer has been acquired by wellness services software developer Mindbody.

Other News

Therachon certifies $810m acquisition
Pfizer will pay $340m upfront and up to an additional $470m in milestone payments to purchase its portfolio company Therachon, providing an exit to Inserm Transfert Initiative.
Canopy finds shelter for Zellkraftwerk
Hannover Medical School chip cytometry spinout Zelkraftwerk has been bought by Canopy Biosciences, providing an exit for tech transfer company Ascenion.
Early Learning awakens with Renaissance
Edtech provider Renaissance has bought UM's early years education assessment provider Early Learning Labs, vindicating twenty years of government-funded research.
SkyDeck exits through Polymorph Labs
Walmart has stepped up to acquire SkyDeck alumnus advertisement platform Polymorph Labs after the latter had raised $10.5m in funding.
Guardant Health buys Bellwether Bio
University of Washington cancer diagnostics spinout Bellwether Bio has been acquired by Guardant Health, which plans to integrate the former's expertise to advance its own pipeline.
Gyroscope enters Orbit for merger
Gyroscope Therapeutics, spun out of Cambridge and Syncona, has merged with Orbit Biomedical to form a fully-integrated retinal gene therapy developer.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Roche derives MS treatment
Versant's unusual build-to-buy model has resulted in Roche acquiring a target for MS based on UCSF research and the venture firm launching a new spinout, Pipeline Therapeutics.
Tsinghua spreads $1.3bn buyout
Tsinghua University offers $1.3bn in a takeover bid of smartphone chipset manufacturer Spreadtrum.
test reg